GSK Beats Third-Quarter Profit Estimates, Keeps Annual Targets
GSK beat third-quarter sales and profit expectations, helped by demand for specialty medicines, and kept its annual targets.
GSK LSE:GSK beat third-quarter sales and profit expectations on Wednesday, helped by demand for specialty medicines, suggesting CEO Luke Miels' efforts to accelerate growth and prepare the drugmaker for looming patent expiries are on track.The British company's core profit for the three-month perio…